Nosebleeds
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sirolimus for Nosebleeds in HHT (NCT05269849) | Unity Health Toronto | 2022-03-16 |
| Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) (NCT01406639) | University of California, San Diego | 2011-07-01 |
Track Nosebleeds automatically
Every clearance here is in the API, with alerts when new ones post.